Drug intelligence / Profile preview

gelsolin

Development stage
Preclinical
Lead developer
BioAegis Therapeutics
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Gelsolin is a multifunctional actin-binding protein that plays a central role in the regulation of actin filament assembly and disassembly. It exists in two main isoforms—cytoplasmic and plasma (secreted)—with the latter containing an additional N-terminal extension. Gelsolin severs and caps actin filaments in a calcium-dependent manner, thereby regulating cytoskeletal dynamics, cell motility, shape, metabolism, and apoptosis. Its activity is modulated by calcium ions (activation) and polyphosphoinositides such as PIP2 (inhibition). Beyond its structural roles, plasma gelsolin acts as an extracellular scavenger of actin released during tissue injury or disease and exhibits anti-inflammatory and immunomodulatory properties. Decreased levels are associated with critical illnesses like sepsis, ARDS, COVID-19-related cytokine storm/ALI/ARDS/MODS, myocardial infarction, liver failure, inflammation states and burns; increased levels are seen after rhabdomyolysis or in amyloidosis. Recombinant human plasma gelsolin has been investigated for therapeutic use to mitigate acute lung injury (ALI), ARDS—including severe COVID-19—and sepsis by scavenging extracellular actin filaments and modulating immune responses[1][4][5][6][7].

Other names
GSNplasma gelsolincytoplasmic gelsolin
02

Targets

Actin filament proteinsMitochondrial apoptosis machinery

Beyond the preview

Go deeper on gelsolin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on gelsolin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call